The efficacy of neoadjuvant chemotherapy is different for type 4 and large type 3 gastric cancer
American journal of surgery(2023)
摘要
•Large type 3 GC in the CSC group had better survival than those in the SC group.•For large type 3 GC, neoadjuvant chemotherapy not only reduced surgical complications but also improved patient survival.•There was no statistically significant difference in survival analysis for type 4 GC between the CSC and SC groups.
更多查看译文
关键词
Gastric cancer,Borrmann,Type 4,Large type 3,Neoadjuvant chemotherapy
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要